Bespoke Extracts (BSPK) Share-based Compensation (2011 - 2025)
Bespoke Extracts' (BSPK) quarterly Share-based Compensation came in at $11390.0 in Q3 2025, down 90.38% year-on-year from $118349.0 in Q3 2024, and up 284.8% quarter-over-quarter from $2960.0 in Q1 2025.
Bespoke Extracts (BSPK) Share-based Compensation (2011 - 2025) Analysis & Trends
Bespoke Extracts has disclosed Share-based Compensation across 10 years of filings, most recently posting $11390.0 for Q3 2025.
- Share-based Compensation for Q3 2025 came in at $11390.0, down 90.38% year-over-year; the trailing twelve-month figure through Sep 2025 was -$138386.0 (down 142.73% YoY), and the FY2024 annual result was $72815.0, down 80.86% from the prior year.
- Share-based Compensation came in at $11390.0 for Q3 2025 at Bespoke Extracts, up from $2960.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $727606.0 in Q1 2022 to a low of -$1.2 million in Q4 2022.
- The 4-year median for Share-based Compensation is $92388.0 (2023), against an average of $63527.6.
- Across the five-year window, Share-based Compensation jumped 108.03% in 2023 and plunged 255.37% in 2024, its largest moves.
- Bespoke Extracts' Share-based Compensation stood at -$1.2 million in 2022, then surged by 108.03% to $98303.0 in 2023, then slumped by 255.37% to -$152736.0 in 2024, then jumped by 107.46% to $11390.0 in 2025.
- The last three Share-based Compensation figures came in at $11390.0 (Q3 2025), $2960.0 (Q1 2025), and -$152736.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Bespoke Extracts | - | - | 234,175.00 | 11,390.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 11,390.00 |
| Sep 30, 2025 | 11,390.00 |
| Mar 31, 2025 | 2,960.00 |
| Mar 31, 2025 | 2,960.00 |
| Dec 31, 2024 | -152,736.00 |
| Dec 31, 2024 | -152,736.00 |
| Sep 30, 2024 | 118,349.00 |
| Sep 30, 2024 | 118,349.00 |
| Jun 30, 2024 | 56,784.00 |
| Jun 30, 2024 | 56,784.00 |
| Mar 31, 2024 | 50,418.00 |
| Mar 31, 2024 | 50,418.00 |
| Dec 31, 2023 | 98,303.00 |
| Dec 31, 2023 | 98,303.00 |
| Sep 30, 2023 | 97,303.00 |
| Sep 30, 2023 | 97,303.00 |
| Jun 30, 2023 | 92,344.00 |
| Jun 30, 2023 | 92,344.00 |
| Mar 31, 2023 | 92,432.00 |
| Mar 31, 2023 | 92,432.00 |